RecruitingNot ApplicableNCT04998175
Multi-omics Research of Idopathic Normal Pressure Hydrocephalus (iNPH)
Multi-omics Research of Prognostic Factors of Ventriculoperitoneal Shunt for Idopathic Normal Pressure Hydrocephalus
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University
Enrollment
40 participants
Start Date
Sep 15, 2020
Study Type
INTERVENTIONAL
Conditions
Summary
The research is designed to study the prognostic factors of ventriculoperitoneal (VP) shunt for iNPH by multi-omics research
Eligibility
Min Age: 60 YearsMax Age: 90 Years
Inclusion Criteria3
- Age ≥ 60 years;
- Diagnosis of iNPH based on clinical assessment
- Participant is able to give written informed consent
Exclusion Criteria3
- Combining AD and Parkinson's disease and other nervous system diseases
- Participant is not medically available for shunt surgery
- Secondary NPH
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREventriculo-peritoneal shunt
A ventriculoperitoneal shunt is a tube that drains excess cerebrospinal fluid into abdomen
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04998175